NO120936B - - Google Patents

Download PDF

Info

Publication number
NO120936B
NO120936B NO159579A NO15957965A NO120936B NO 120936 B NO120936 B NO 120936B NO 159579 A NO159579 A NO 159579A NO 15957965 A NO15957965 A NO 15957965A NO 120936 B NO120936 B NO 120936B
Authority
NO
Norway
Prior art keywords
oxo
compounds
residue
nitro
general formula
Prior art date
Application number
NO159579A
Other languages
English (en)
Norwegian (no)
Inventor
P Schmidt
M Wilhelm
K Eichenberger
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1080063A external-priority patent/CH459232A/de
Priority claimed from CH539564A external-priority patent/CH463514A/de
Priority claimed from CH1153464A external-priority patent/CH457454A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NO120936B publication Critical patent/NO120936B/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
NO159579A 1962-05-30 1965-09-02 NO120936B (en:Method)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
CH660462A CH400171A (de) 1962-05-30 1962-05-30 Verfahren zur Herstellung neuer heterocyclischer Verbindungen
CH505663 1963-04-23
CH1080063A CH459232A (de) 1963-08-30 1963-08-30 Verfahren zur Herstellung neuer Imidazole
CH539564A CH463514A (de) 1964-04-24 1964-04-24 Verfahren zur Herstellung neuer Diazacycloalkanverbindungen
CH896164 1964-07-08
CH1153464A CH457454A (de) 1964-09-03 1964-09-03 Verfahren zur Herstellung neuer Diazacycloalkanverbindungen
CH294965 1965-03-03
CH442365 1965-03-31
US28258965A 1965-04-13 1965-04-13
US44786865A 1965-04-13 1965-04-13
CH1019865 1965-07-20

Publications (1)

Publication Number Publication Date
NO120936B true NO120936B (en:Method) 1970-12-28

Family

ID=27581426

Family Applications (1)

Application Number Title Priority Date Filing Date
NO159579A NO120936B (en:Method) 1962-05-30 1965-09-02

Country Status (13)

Country Link
US (2) US3299069A (en:Method)
BE (4) BE652414A (en:Method)
BR (4) BR6349499D0 (en:Method)
CH (2) CH400171A (en:Method)
CY (1) CY328A (en:Method)
DE (4) DE1445632C3 (en:Method)
FR (6) FR3836M (en:Method)
GB (6) GB986562A (en:Method)
IL (1) IL24140A (en:Method)
MY (1) MY6600002A (en:Method)
NL (5) NL6505225A (en:Method)
NO (1) NO120936B (en:Method)
SE (4) SE311905B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH462830A (de) * 1965-01-20 1968-09-30 Ciba Geigy Verfahren zur Herstellung von 1-(5-Nitrothiazolyl-(2))-2-oxo-tetrahydroimidazolen
US3444168A (en) * 1966-12-30 1969-05-13 Sterling Drug Inc 6 - (lower-alkanoyl) - 4 - hydroxy - 2 - mercapto - 5,6,7,8 - tetrahydropyrido(4,3 - d)pyrimidines
US3627777A (en) * 1969-11-03 1971-12-14 Ciba Geigy Corp N-thiazolyl-oxodiazacycloalkanes
US3925550A (en) * 1971-03-23 1975-12-09 Rhone Poulenc Sa 1-(5-Nitrothi-alzol-2-yl)-imidazolidine-2-thione having anti-parasitic and anti-microbial properties
US3932410A (en) * 1974-11-01 1976-01-13 Velsicol Chemical Corporation 1-Thiadiazolyl-6-alkoxytetrahydropyrimidinones
NZ199856A (en) * 1981-03-09 1984-08-24 Johnson & Johnson Baby Prod Non-zwitterionic amphoteric-fatty acid complexes and detergent compositions
FR2552804B1 (fr) * 1983-10-03 1986-07-25 Lauragais Tuileries Briq Panneau prefabrique pour le revetement de parois, procedes de fabrication et de mise en oeuvre, et plaquettes en terre cuite pour la realisation desdits panneaux
PE20110341A1 (es) 2006-08-15 2011-06-21 Novartis Ag COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2755285A (en) * 1956-07-17 I-xsubstituted
US2874149A (en) * 1957-03-18 1959-02-17 Monsanto Chemicals Ureas

Also Published As

Publication number Publication date
GB1078314A (en) 1967-08-09
DE1545693C3 (de) 1975-04-03
CY328A (en) 1965-11-06
DE1545666B2 (de) 1974-06-06
DE1245971B (de) 1967-08-03
CH459234A (de) 1968-07-15
DE1545693B2 (de) 1974-07-11
NL6604864A (en:Method) 1966-10-14
GB1078312A (en) 1967-08-09
BE632989A (en:Method)
BE669083A (en:Method) 1966-03-02
SE321232B (en:Method) 1970-03-02
DE1545693A1 (de) 1969-11-27
MY6600002A (en) 1966-12-31
GB1075199A (en) 1967-07-12
FR3836M (fr) 1966-01-10
BR6572735D0 (pt) 1973-08-16
GB1078313A (en) 1967-08-09
NL6511486A (en:Method) 1966-03-04
FR4613M (en:Method) 1966-11-21
SE311905B (en:Method) 1969-06-30
FR4981M (en:Method) 1967-04-10
GB1065988A (en) 1967-04-19
BE671753A (en:Method) 1966-05-03
DE1545666A1 (de) 1969-06-26
FR4671M (en:Method) 1966-12-12
BR6462227D0 (pt) 1973-08-07
NL6505225A (en:Method) 1965-10-25
NL123747C (en:Method)
IL24140A (en) 1969-07-30
GB986562A (en) 1965-03-17
BE652414A (en:Method) 1965-03-01
DE1445632C3 (de) 1975-11-13
BR6349499D0 (pt) 1973-06-28
CH400171A (de) 1965-10-15
DE1545666C3 (de) 1975-02-20
FR3818M (fr) 1966-01-03
BR6569146D0 (pt) 1973-08-02
DE1445632B2 (de) 1975-04-03
SE311911B (en:Method) 1969-06-30
US3299069A (en) 1967-01-17
FR4982M (en:Method) 1967-04-10
NL145552B (nl) 1975-04-15
US3298914A (en) 1967-01-17
SE311910B (en:Method) 1969-06-30
NL293361A (en:Method)
DE1445632A1 (de) 1968-12-12

Similar Documents

Publication Publication Date Title
NO159579B (no) Fremgangsm te fo styre et lysbuesveisehode.
FI68618C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazolidinderivat
KR100370888B1 (ko) 우레아유도체에의한류코트라이인생합성의억제
NO151797B (no) Apparat for toemming av beholdere hvori gass er lagret opploest under trykk i et opploesningsmiddel
US3770763A (en) N-(2-(nitro-1-imidazoly)ethyl)imides
US3399211A (en) Production of 2-aryl-4(5)-nitroimidazoles
NO120936B (en:Method)
CN112898311A (zh) 一种吲哚螺吡啶并香豆素类化合物及其制备方法与应用
US3652579A (en) 1-methyl-2-substituted 5-nitroimidazoles
US3448116A (en) Preparation of 1-hydroxyhydantoins and 1-hydroxythiohydantoins
NO120075B (en:Method)
DE69708484T2 (de) Pyridinderivate,als Arzneimittel zur Behandlung von Geschwüren und als antibakterielle Mittel
US3997572A (en) N-[2-(nitro-1-imidazolyl)ethyl]naphthal imides
CN112679409B (zh) 一种4-吲哚-取代硫半脲衍生物及其制备方法和应用
US4115641A (en) Ribofuranosyl-imidazole derivatives
SU1156597A3 (ru) Способ получени производных 3-( @ -алкилсульфонилфенил)оксазолидинона или их фармацевтически приемлемых кислотно-аддитивных солей
US3968103A (en) 1,2,3-Triazole nucleosides
US3346568A (en) 2-amino-5-sulfamyl-benzoic acid hydrazides
RU2763728C1 (ru) Применение 3-(2-(4-нитрофенил)-2-оксоэтилиден)морфолин-2-она в качестве средства, обладающего противомикробной активностью
RU2828097C1 (ru) СПОСОБ ОЧИСТКИ (4R,12aS)-N-(2,4-ДИФТОРБЕНЗИЛ)-7-ГИДРОКСИ-4-МЕТИЛ-6,8-ДИОКСО-3,4,6,8,12,12a-ГЕКСАГИДРО-2Н-ПИРИДО[1',2':4,5]ПИРАЗИНО[2,1-b][1,3]ОКСАЗИН-9-КАРБОКСАМИДА
US4053472A (en) 2-(5-nitro-2-imidazolyl)-benzimidazoles
RU2828100C1 (ru) СПОСОБ ОЧИСТКИ (4R,12aS)-N-(2,4-ДИФТОРБЕНЗИЛ)-7-ГИДРОКСИ-4-МЕТИЛ-6,8-ДИОКСО-3,4,6,8,12,12a-ГЕКСАГИДРО-2Н-ПИРИДО[1',2':4,5]ПИРАЗИНО[2,1-b][1,3]ОКСАЗИН-9-КАРБОКСАМИДА
SU422152A3 (ru) Способ получения производных 1-
RU2826759C1 (ru) Способ очистки (4r,12as)-n-(2,4-дифторбензил)-7-гидрокси-4-метил-6,8-диоксо-3,4,6,8,12,12а-гексагидро-2н-пиридо[1',2':4,5]пиразино[2,1-b][1,3]оксазин-9-карбоксамида натрия
RU2828091C1 (ru) СПОСОБ ОЧИСТКИ СОЕДИНЕНИЯ (4R,12aS)-N-(2,4-ДИФТОРБЕНЗИЛ)-7-МЕТОКСИ-4-МЕТИЛ-6,8-ДИОКСО-3,4,6,8,12,12a-ГЕКСАГИДРО-2Н-ПИРИДО[1',2':4,5]ПИРАЗИНО[2,1-b][1,3]ОКСАЗИН-9-КАРБОКСАМИДА